NEWS IN BRIEF

CMAB to provide development service for ‘first in class’ Chinese-developed biologic

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Rawpixel)
(Image: Getty/Rawpixel)

Related tags: CMAB Biopharma, Fapon Biopharma, China

CMAB Biopharma will provide development and manufacturing services for Fapon Biopharma’s potential oncology drug product.

Chinese contract development and manufacturing organization (CDMO), CMAB Biopharma will aid Fapon Biopharma in progressing its unspecified oncology drug candidate through to investigational new drug (NDA) applications to the US and China regulators.

Fapon is a supplier of raw materials and solutions for in vitro ​diagnostic reagents, but has also cultivated a drug pipeline through an R&D center based in Shanghai – the result of a ¥100m ($14m) investment.

Very few details on the drug candidate are provided by the announcement​ or through Fapon’s website; however, the company states that it has monoclonal antibodies, fusion proteins and cell therapy products in its pipeline.

In addition, the product is a potential ‘first in class’ treatment and has shown “significant promise”​ in the treatment of lung, stomach and colorectal cancers.

For CMAB, it represents the second clinical development deal it has signed in recent months for an oncology candidate.

The CDMO previously announced that it would work with Kintor Pharmaceuticals​ to develop an antibody that had previously been developed by Pfizer, with the drug candidate now in Phase II clinical trials.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us

Products

View more

Webinars